Patent · US Active

Antibodies against human CSF-1R and uses thereof

US10072087B2 · kind B2 · utility

5Cited by
34References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 21, 2017
Grant dateSep 11, 2018
Priority date
Expiry dateDec 21, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to antibodies against human CSF-1R (anti-CSF-1R antibody), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.